The current OTLK market cap is 48.32M. The company's latest EPS is USD -2.3540 and P/E is -0.64.
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -36.84M | -51.77M | -63.12M | -53.14M | -71.8M |
Net Income | -48.87M | -53.16M | -66.05M | -58.98M | -75.37M |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 19.73M | 22.81M | 28.53M | 32.3M | 28.82M |
Total Liabilities | 16.91M | 18.2M | 19.79M | 46.74M | 101.9M |
Total Equity | 2.83M | 4.61M | 8.74M | -14.44M | -73.08M |
Market Cap | 48.32M |
Price to Earnings Ratio | -0.64 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.22 |
Price to Book Ratio | -0.66 |
Dividend Yield | - |
Shares Outstanding | 32.02M |
Average Volume (1 week) | 282.52k |
Average Volume (1 Month) | 404.7k |
52 Week Change | -77.87% |
52 Week High | 12.8499 |
52 Week Low | 0.87 |
Spread (Intraday) | 0.16 (9.94%) |
Company Name | Outlook Therapeutics Inc |
Address |
800 north state street dover, delaware 19901 |
Website | https://www.outlooktherapeutics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions